<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01484639</url>
  </required_header>
  <id_info>
    <org_study_id>TRICSII</org_study_id>
    <secondary_id>Application #232416</secondary_id>
    <nct_id>NCT01484639</nct_id>
  </id_info>
  <brief_title>Transfusion Requirements in Cardiac Surgery</brief_title>
  <acronym>TRICSII</acronym>
  <official_title>Transfusion Requirements in Cardiac Surgery (TRICS II): A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nadine Shehata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-centre randomized controlled pilot trial of two transfusion strategies in
      high risk patients having cardiac surgery. This study will be conducted in 7 Canadian centers
      and 1 American centre. Patients allocated to a &quot;restrictive&quot; transfusion strategy will
      receive a red cell transfusion if their hemoglobin is 75 g/L or less intraoperatively and
      postoperatively. Patients allocated to a &quot;liberal&quot; transfusion strategy will receive red cell
      transfusion if their hemoglobin concentration is 95 g/L or less intraoperatively and
      postoperatively in the intensive care unit, and less than 85 g/L on the ward.

      The primary objectives of this study are to determine 1) enrollment rates (patients
      enrolled/patients eligible), 2) consent rates (consent obtained/patients approached); and 3)
      protocol adherence (incidence and reasons for non adherence, lack of consent, rates of
      contamination and utilization of co-interventions). The secondary objectives are to determine
      1) the mortality rate and the rate of the composite outcome for morbidity of renal, cardiac,
      neurological and infectious adverse events; 2) the proportion of missing data as a measure of
      the feasibility of the case report form; and 3) the proportion of blood products utilized
      (red cells, platelets and plasma).

      The results of the multicentre pilot study will be used to 1) maximize enrollment rates to
      ensure timely completion of recruitment of a definitive large randomized controlled trial, 2)
      maximize adherence rates, 3) determine event rates for sample size estimation for a
      definitive study, and to 4) optimize the case report form.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Enrollment rate</measure>
    <time_frame>baseline</time_frame>
    <description>To determine enrollment rates (patients enrolled/patients eligible), consent rates (consent obtained/patients approached)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Protocol adherence</measure>
    <time_frame>28 days or hospital discharge</time_frame>
    <description>To determine protocol adherence (incidence and reasons for non adherence, lack of consent, rates of contamination and utilization of co-interventions).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality and morbidity</measure>
    <time_frame>28 days or hospital discharge</time_frame>
    <description>To determine the mortality rate and a composite outcome for morbidity (renal, cardiac, neurological and infectious adverse events).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Missing data</measure>
    <time_frame>28 days or hospital discharge</time_frame>
    <description>To determine the proportion of missing data as a measure of the feasibility of the case report form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood product utilization</measure>
    <time_frame>28 days or hospital discharge</time_frame>
    <description>To determine the proportion of blood products utilized (red cells, platelets and plasma)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">208</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Restrictive transfusion triggers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients allocated to a &quot;restrictive&quot; transfusion group will receive a red cell transfusion if their hemoglobin is 75 g/L or less intraoperatively and postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liberal transfusion triggers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients allocated to a &quot;liberal&quot; transfusion strategy will receive red cell transfusion if their hemoglobin concentration is 95 g/L or less intraoperatively and postoperatively in the intensive care unit, and less than 85 g/L on the ward.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liberal transfusion triggers</intervention_name>
    <description>Patients allocated to a &quot;liberal&quot; transfusion strategy will receive red cell transfusion if their hemoglobin concentration is 95 g/L or less intraoperatively and postoperatively in the intensive care unit, and less than 85 g/L on the ward.</description>
    <arm_group_label>Liberal transfusion triggers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Restrictive transfusion triggers</intervention_name>
    <description>Patients allocated to a &quot;restrictive&quot; transfusion group will receive a red cell transfusion if their hemoglobin is 75 g/L or less intraoperatively and postoperatively.</description>
    <arm_group_label>Restrictive transfusion triggers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  European System for Cardiac Operative Risk Evaluation (EuroSCORE) of 6 or more

          -  Consent

        Exclusion Criteria:

          -  Pregnancy

          -  Refusal of blood products

          -  Participating in autologous blood donation program

          -  Based on the preoperative hemoglobin, the predicted hematocrit on cardiopulmonary
             bypass is greater than 33% (hemoglobin concentration of 110 g/L) or less than 18%
             (hemoglobin concentration of 60 g/L)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadine Shehata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Li Ka Shing Knowledge Institute, Mount Sinai Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Mazer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alberta Health Services</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Boniface General Hospital</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R2H 2A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y 4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2011</study_first_submitted>
  <study_first_submitted_qc>November 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2011</study_first_posted>
  <last_update_submitted>February 20, 2013</last_update_submitted>
  <last_update_submitted_qc>February 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>St. Michael's Hospital, Toronto</investigator_affiliation>
    <investigator_full_name>Nadine Shehata</investigator_full_name>
    <investigator_title>Principal Investigator-Sponsor</investigator_title>
  </responsible_party>
  <keyword>transfusion</keyword>
  <keyword>cardiac surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

